Home Table of Contents

§ 1735. Compounding in Licensed Pharmacies.

16 CA ADC § 1735Barclays Official California Code of Regulations

Barclays California Code of Regulations
Title 16. Professional and Vocational Regulations
Division 17. California State Board of Pharmacy (Refs & Annos)
Article 4.5. Compounding
16 CCR § 1735
§ 1735. Compounding in Licensed Pharmacies.
Currentness
(a) “Compounding” means any of the following activities occurring in a licensed pharmacy, by or under the supervision of a licensed pharmacist, pursuant to a prescription:
(1) Altering the dosage form or delivery system of a drug
(2) Altering the strength of a drug
(3) Combining components or active ingredients
(4) Preparing a compounded drug preparation from chemicals or bulk drug substances
(b) “Compounding” does not include reconstitution of a drug pursuant to a manufacturer's direction(s), nor does it include the sole act of tablet splitting or crushing, capsule opening, or the addition of flavoring agent(s) to enhance palatability.
(c) The parameters and requirements stated by Article 4.5 (Section 1735 et seq.) apply to all compounding practices. Additional parameters and requirements applicable solely to sterile compounding are stated by Article 7 (Section 1751 et seq.).

Credits

Note: Authority cited: Sections 4005 and 4127, Business and Professions Code. Reference: Sections 4005, 4036, 4037, 4051, 4052 and 4127, Business and Professions Code.
History
1. New article 4.5 (sections 1735-1735.8) and section filed 1-6-2010; operative 7-6-2010 (Register 2010, No. 2).
2. Amendment of subsections (a)(4) and (b), repealer of subsection (c), subsection relettering and amendment of newly designated subsection (c) filed 9-13-2016; operative 1-1-2017 (Register 2016, No. 38).
This database is current through 5/24/24 Register 2024, No. 21.
Cal. Admin. Code tit. 16, § 1735, 16 CA ADC § 1735
End of Document